U.S. Markets closed

AmerisourceBergen Corporation (ABC)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
89.97+0.78 (+0.87%)
At close: 4:00PM EDT

89.97 0.00 (0.00%)
After hours: 4:32PM EDT

People also watch
CAHMCKABGAFGAEB

AmerisourceBergen Corporation

1300 Morris Drive
Chesterbrook, PA 19087
United States
610-727-7000
http://www.amerisourcebergen.com

SectorServices
IndustryDrugs Wholesale
Full Time Employees18,000

Key Executives

NameTitlePayExercisedAge
Mr. Steven H. CollisChairman, Chief Exec. Officer and Pres3.28M14.32M56
Mr. Tim G. GuttmanChief Financial Officer and Exec. VP1.37MN/A58
Mr. John G. ChouExec. VP and Gen. Counsel1.19M3.72M61
Mr. James D. FraryExec. VP and Pres of AmerisourceBergen Speciality Group1.49MN/A45
Dr. Robert P. Mauch PharmD, Ph.D.Exec. VP and Pres of AmerisourceBergen Drug Corp.974.77k661.81k50
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment provides pharmaceutical distribution and other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers third party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers. The company’s Other segment provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and co-pay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers; specialty transportation and logistics services for the biopharmaceutical industry; and animal health care products. It markets its products and services through independent sales forces and marketing organizations. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.

Corporate Governance

AmerisourceBergen Corporation’s ISS Governance QualityScore as of May 1, 2017 is 2. The pillar scores are Audit: 1; Board: 2; Shareholder Rights: 4; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.